Vascular Biogenics Ltd (VBLT)

[Oren1976]

My calculations also show without any doubt primary endpoint met already this is why I believe that for the benefit of the people in trial they should stop it. They won't do it because we are few months before end of trial but there is a chance they will do it. My calculation is simple . Let's assume all patients started trial Oct 2016 while we know trial started aug2015. So I give a huge interval here . 1 year overall survival avastin is 25% alive 75% died. From 256 192 should die Oct 17 but we know only December or January 18 189 events occur...it means without any doubt primary endpoint was met again I took October 16 as the month all patients recruited while trial started over a year before!